Rhizomelic Chondrodysplasia Punctata Type 5

Mendelian MONDO:0014743 Pathograph 13 Show in embeddings browser Rhizomelic Chondrodysplasia Punctata Peroxisome Biogenesis Disorder

Rhizomelic chondrodysplasia punctata type 5 is caused by biallelic PEX5 variants that remove the long isoform of the protein while sparing the short one. It exists as a distinct entity because of an isoform accident with unusually clean mechanistic consequences. PEX5 is the cytosolic receptor for peroxisomal matrix proteins carrying targeting signal 1, and it is transcribed as two isoforms: PEX5S, which does PTS1 import only, and PEX5L, which does PTS1 import and additionally acts as the co-receptor through which PEX7 delivers PTS2-tagged cargo. Every previously reported PEX5 patient had a Zellweger spectrum disorder, because their variants knocked out PTS1 import. The RCDP5 variant sits in exon 9, which is specific to the long isoform, so PTS1 import survives intact and only the PTS2 arm fails - reproducing exactly the lesion that PEX7 loss produces in RCDP1, from the other side of the same receptor complex. One gene therefore gives two unrelated diseases depending on which isoform an allele hits, and the practical consequence is stated in the founding paper: a patient with a selective PTS2 import defect needs PEX7 sequenced and PEX5 exon 9 sequenced, because the biochemistry alone will not tell them apart. Clinically the four reported patients had congenital cataracts, postnatal growth delay, microcephaly, and severe intellectual disability, but only mild humeral shortening in three and chondrodysplasia punctata in two - a milder and less consistently rhizomelic skeletal picture than classic RCDP1, which matters when deciding whether to look for the disorder at all.

Ask OpenScientist

Ask a research question about Rhizomelic Chondrodysplasia Punctata Type 5. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Mappings
1
Inheritance
6
Pathophys.
7
Phenotypes
1
Gaps
13
Pathograph
1
Genes
2
Medical Actions
3
Differentials
2
References
🏷

Classifications

Harrison's Part
GENETICS ENVIRONMENT DISEASE ENDOCRINOLOGY METABOLISM
ICIMD (Inherited Metabolic Disorders)
peroxisomal biogenesis
ISDS Skeletal Nosology
chondrodysplasia punctata
🔗

Mappings

MONDO
MONDO:0014743 rhizomelic chondrodysplasia punctata type 5
skos:exactMatch MONDO
The dismech entry and the MONDO class denote the same entity: PEX5-related rhizomelic chondrodysplasia punctata arising from loss of the PEX5 long isoform. The other PEX5 phenotype, Zellweger spectrum disorder from loss of PTS1 import, is a separate concept and is handled here as a differential.
👪

Inheritance

1
Autosomal recessive inheritance HP:0000007
All four reported patients were homozygous for the same frameshift allele, in two independent families.
autosomal recessive inheritance
Show evidence (1 reference)
PMID:26220973 SUPPORT Human Clinical
"In four patients with RCDP from two independent families, we identified a homozygous frame shift mutation"
Documents homozygosity in two independent families.
?

Discussions and Knowledge Gaps

1
Is the milder, less consistently rhizomelic skeletal phenotype of RCDP5 a real property of the disorder, or an artefact of the single allele on which the entity was defined?
KNOWLEDGE GAP OPEN rcdp5_phenotypic_boundary
All four described patients are homozygous for one frameshift in two families, so the entity's clinical description and its genotype are entirely confounded. The reported phenotype - chondrodysplasia punctata in only two of four, mild humeral shortening in three, survival into the second decade - is milder than classic RCDP1 and would fit the nonclassic RCDP pattern. Whether that reflects the isoform lesion, this particular allele, or the two families is untestable on the published cohort. It matters for ascertainment: if RCDP5 is genuinely milder, patients are being missed, since a plasmalogen screen showing only mild reduction in a child without striking rhizomelia is unlikely to prompt PEX5 exon 9 sequencing.
Proposed experiments
Broader ascertainment of PEX5L-selective alleles
rcdp5_allelic_series
Targeted analysis of PEX5 exon 9 in cohorts with a selective PTS2 import defect and no PEX7 variant, to determine whether other PEX5L-selective alleles exist and whether they reproduce the attenuated skeletal phenotype.
Show evidence (1 reference)
PMID:26220973 SUPPORT Human Clinical
"mild shortening of humeri in three patients, and chondrodysplasia punctata in two patients,"
The per-feature counts show that the defining skeletal features were not present in every patient, which is the observation the question turns on.

Pathophysiology

6
Loss of the PEX5 Long Isoform
PEX5 is transcribed as two isoforms. Both PEX5L and PEX5S recognize PTS1-tagged cargo, but only PEX5L serves as the co-receptor for PEX7-mediated import of PTS2-tagged cargo. The RCDP5 frameshift lies in exon 9, which is present only in the long transcript, so it removes PEX5L and leaves PEX5S intact. This is the whole mechanism of the disorder and the reason it is not a Zellweger spectrum disorder.
Genetic context PEX5 hgnc:9719 HUGO Gene Nomenclature Committee (hgnc) Relation: this genetic context concerns this gene This genetic context concerns PEX5 (hgnc:9719). hgnc:9719 is a gene from the HUGO Gene Nomenclature Committee. variant_origin: GERMLINE zygosity: HOMOZYGOUS functional_impact_category: LOSS_OF_FUNCTION
Homozygous frameshift in the PEX5L-specific exon 9 in all four reported patients from two independent families. The functional impact is isoform-selective rather than whole-gene: PEX5S is unaffected, which is why PTS1 import is preserved.
protein import into peroxisome matrix GO:0016558 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased protein import into peroxisome matrix (GO:0016558). GO:0016558 is a biological process from the Gene Ontology. ↓ DECREASED
Show evidence (2 references)
PMID:26220973 SUPPORT Human Clinical
"PEX5 encodes two isoforms, PEX5L and PEX5S, and we show that the c.722dupA mutation, located in the PEX5L-specific exon 9, results in loss of PEX5L only."
Establishes the isoform-selective consequence of the variant.
PMID:26220973 SUPPORT In Vitro
"We demonstrate that PEX5L expression restores the import of PTS2-tagged proteins in patient fibroblasts."
Complementation of patient fibroblasts with PEX5L restores the defective function, establishing causation rather than association.
Selective PTS2 Import Failure
An isolated failure to import the three known PTS2-tagged peroxisomal matrix proteins: alkyl-DHAP synthase (AGPS), which makes the ether bond in plasmalogens; phytanoyl-CoA 2-hydroxylase (PHYH), which performs phytanic-acid alpha-oxidation; and acetyl-CoA acyltransferase 1 (ACAA1). Peroxisomes are otherwise assembled and PTS1 import is normal, so this is a targeted functional lesion rather than a general peroxisome biogenesis failure - which is why the disorder is an RCDP and not a Zellweger spectrum disorder. The node is deliberately named to match the corresponding node in the RCDP1 entry, since the two disorders converge on it from opposite sides of the same receptor pair.
protein targeting to peroxisome GO:0006625 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased protein targeting to peroxisome (GO:0006625). GO:0006625 is a biological process from the Gene Ontology. ↓ DECREASED protein import into peroxisome matrix GO:0016558 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased protein import into peroxisome matrix (GO:0016558). GO:0016558 is a biological process from the Gene Ontology. ↓ DECREASED
peroxisome GO:0005777 Gene Ontology (GO) Relation: this pathophysiological event involves this cellular component This pathophysiological event involves peroxisome (GO:0005777). GO:0005777 is a cellular component from the Gene Ontology.
Show evidence (1 reference)
PMID:26220973 SUPPORT In Vitro
"Similarly to mutations in PEX7, loss of PEX5L results in deficient import of PTS2-tagged proteins only, thus causing RCDP instead of ZSD."
States both the selectivity of the import defect and the nosological consequence that follows from it.
Plasmalogen (Ether Lipid) Deficiency
Reduced cellular plasmalogens, the shared endpoint of every RCDP type. In the reported RCDP5 patients the reduction was mild rather than profound, which fits their milder and less consistently rhizomelic skeletal phenotype but also means the disorder can be missed on a plasmalogen screen alone.
ether lipid biosynthesis GO:0008611 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased ether lipid biosynthesis, annotated with ether lipid biosynthetic process (GO:0008611). GO:0008611 is a biological process from the Gene Ontology. ↓ DECREASED
Show evidence (1 reference)
PMID:26220973 SUPPORT Human Clinical
"Three additional RCDP types, RCDP2-3-4, are caused, respectively, by mutations in GNPAT, AGPS and FAR1, encoding enzymes involved in plasmalogen biosynthesis."
Places the plasmalogen pathway as the common convergence point across RCDP types, reached here through import failure rather than through enzyme loss.
Phytanic Acid Accumulation
Loss of peroxisomal phytanic-acid alpha-oxidation, following failure to import PHYH. In the reported patients plasma phytanic acid was highly elevated and fibroblast alpha-oxidation markedly reduced - a more striking abnormality than their mild plasmalogen reduction, and the finding that most clearly marks the disorder as an import-receptor rather than a single-enzyme RCDP.
fatty acid alpha-oxidation GO:0001561 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased fatty acid alpha-oxidation (GO:0001561). GO:0001561 is a biological process from the Gene Ontology. ↓ DECREASED
Show evidence (1 reference)
PMID:26220973 SUPPORT Other
"phytanoyl-CoA 2-hydroxylase (PHYH) (28), involved in phytanic acid"
Identifies phytanoyl-CoA 2-hydroxylase, the enzyme of phytanic-acid alpha-oxidation, as PTS2-tagged cargo - so a selective PTS2 import failure necessarily blocks that pathway.
Skeletal Dysplasia
Disordered endochondral ossification with punctate epiphyseal calcification and proximal limb shortening. In RCDP5 this arm of the phenotype is attenuated relative to classic RCDP1: humeral shortening was mild and present in three of four patients, and chondrodysplasia punctata in only two.
chondrocyte CL:0000138 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves chondrocyte (CL:0000138). CL:0000138 is a cell type from the Cell Ontology. growth plate cartilage chondrocyte CL:1000217 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves growth plate cartilage chondrocyte (CL:1000217). CL:1000217 is a cell type from the Cell Ontology.
endochondral ossification GO:0001958 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal endochondral ossification (GO:0001958). GO:0001958 is a biological process from the Gene Ontology. ⚠ ABNORMAL
Show evidence (1 reference)
PMID:26220973 SUPPORT Human Clinical
"mild shortening of humeri in three patients, and chondrodysplasia punctata in two patients,"
Gives the frequency and severity of the two skeletal features in the founding cohort.
Neurological Impairment
Severe intellectual disability in all four patients, with microcephaly, seizures with epileptiform EEG, and in at least one patient findings compatible with a chronic demyelinating peripheral neuropathy - the last being a feature more usually associated with the Zellweger spectrum than with classic RCDP.
Show evidence (1 reference)
PMID:26220973 SUPPORT Human Clinical
"postnatal growth delay, microcephaly and severe intellectual disability in all four patients"
States the neurological findings and that they were present in all four patients.

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Rhizomelic Chondrodysplasia Punctata Type 5 Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.

Phenotypes

7
Eye 1
Congenital Cataract HP:0000518 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Cataract (HP:0000518), qualified as congenital onset. HP:0000518 is a phenotype from the Human Phenotype Ontology.
Onset: CONGENITAL
Show evidence (1 reference)
PMID:26220973 SUPPORT Human Clinical
"In contrast, some of their key features such as congenital cataracts and chondrodysplasia punctata are usually associated with RCDP"
Records congenital cataract in the cohort and identifies it as an RCDP-typical rather than ZSD-typical feature.
Head and Neck 1
Microcephaly HP:0000252 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Microcephaly (HP:0000252). HP:0000252 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:26220973 SUPPORT Human Clinical
"postnatal growth delay, microcephaly and severe intellectual disability in all four patients"
States microcephaly in all four patients.
Limbs 1
Short Humerus HP:0005792 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Short humerus (HP:0005792), qualified as severity mild. HP:0005792 is a phenotype from the Human Phenotype Ontology.
Severity: MILD
Show evidence (1 reference)
PMID:26220973 SUPPORT Human Clinical
"mild shortening of humeri in three patients"
States the severity and frequency of the humeral shortening.
Nervous System 2
Severe Intellectual Disability HP:0010864 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Severe intellectual disability (HP:0010864). HP:0010864 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:26220973 SUPPORT Human Clinical
"microcephaly and severe intellectual disability in all four patients"
States the finding and its frequency.
Seizure HP:0001250 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Seizure (HP:0001250). HP:0001250 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:26220973 SUPPORT Human Clinical
"developed seizures, and an EEG"
Documents seizures with EEG confirmation in a reported patient.
Growth 1
Postnatal Growth Retardation HP:0008897 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Postnatal growth retardation (HP:0008897). HP:0008897 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:26220973 SUPPORT Human Clinical
"postnatal growth delay, microcephaly and severe intellectual"
States postnatal growth delay in the cohort.
Other 1
Epiphyseal Stippling HP:0010655 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Epiphyseal stippling (HP:0010655). HP:0010655 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:26220973 SUPPORT Human Clinical
"and chondrodysplasia punctata in two patients,"
Gives the frequency of the punctate calcification in the founding cohort.
🧬

Genetic Associations

1
PEX5
Gene: PEX5 hgnc:9719 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is PEX5 (hgnc:9719). hgnc:9719 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE
Show evidence (2 references)
PMID:26220973 SUPPORT Human Clinical
"Previous patients with PEX5 mutations had ZSD, mainly due to deficient import of PTS1-tagged proteins."
Establishes the contrasting PEX5 phenotype and the import defect that produces it.
PMID:26220973 SUPPORT Human Clinical
"Mutations in PEX5 or 12 other PEX genes cause peroxisome biogenesis disorders, collectively named the Zellweger spectrum disorders (ZSDs), whereas mutations in PEX7 cause rhizomelic chondrodysplasia punctata type 1 (RCDP1)."
States the pre-existing gene-disease assignments that RCDP5 complicates, since it places PEX5 on both sides of that division.
💊

Medical Actions

2
Supportive and rehabilitative care
Action: supportive careNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is supportive care (NCIT:C15747). NCIT:C15747 is a clinical intervention from the NCI Thesaurus. Ontology label: Supportive Care NCIT:C15747
No disease-modifying therapy exists. Management follows the RCDP pattern: cataract surgery, developmental and orthopedic support, and seizure management.
Show evidence (1 reference)
PMID:20301447 SUPPORT Human Clinical
"Physical therapy to improve contractures; orthopedic procedures may improve function in some individuals; consider need for positioning and mobility devices"
Support is partial: the source describes management of PEX7-related RCDP, and is cited here on the basis that RCDP5 shares its lesion and clinical problems. No RCDP5-specific management literature exists.
Cataract extraction
Action: surgical procedureNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is surgical procedure (NCIT:C15329). NCIT:C15329 is a clinical intervention from the NCI Thesaurus. Ontology label: Surgical Procedure NCIT:C15329
Surgical removal of the congenital cataracts, performed in the first months of life in all four reported patients.
Target Phenotypes: cataract HP:0000518 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets cataract (HP:0000518). HP:0000518 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:26220973 SUPPORT Human Clinical
"Congenital cataracts were operated at 4 months"
Documents cataract surgery in the reported cohort.
🔬

Biochemical Markers

2
Erythrocyte or fibroblast plasmalogens
Show evidence (1 reference)
PMID:26220973 SUPPORT Other
"All RCDP types are characterized by low levels of plasmalogens"
Establishes reduced plasmalogens as the expected finding in every RCDP type.
Plasma phytanic acid
Show evidence (1 reference)
PMID:26220973 SUPPORT Other
"phytanoyl-CoA 2-hydroxylase (PHYH) (28), involved in phytanic acid"
Identifies phytanoyl-CoA 2-hydroxylase as PTS2-tagged cargo, which is why an import defect raises phytanic acid while a defect in a plasmalogen-synthesis enzyme does not.
🔬

Diagnosis

1
Sequencing PEX7 and PEX5 exon 9 in a selective PTS2 import defect
Because RCDP1 and RCDP5 are biochemically indistinguishable, a patient shown to have a selective PTS2 import defect needs both genes tested. The founding paper makes this an explicit recommendation, and it is the disorder's main practical consequence for laboratory workflow.
molecular genetic testing NCIT:C15709 NCI Thesaurus (NCIT)
Show evidence (1 reference)
PMID:26220973 SUPPORT Human Clinical
"Due to the biochemical overlap between RCDP1 and RCDP5, sequencing of PEX7 and exon 9 in PEX5 should be performed in patients with a selective defect in the import of PTS2-tagged proteins."
States the testing recommendation and the reason for it.
📈

Progression

3
Infancy - congenital cataracts
All four reported patients had congenital cataracts requiring surgery in the first months. As in RCDP1, the cataract is the earliest and most consistent feature and typically precedes recognition of the metabolic disorder.
Show evidence (1 reference)
PMID:26220973 SUPPORT Human Clinical
"the phenotype in our patients, including congenital cataracts,"
Records congenital cataracts as a feature of the reported cohort.
Early childhood - growth delay, microcephaly, developmental impairment
Growth delay and microcephaly emerge after the first one to two years, with severe intellectual disability in all four patients. Seizures with epileptiform EEG developed in several.
Show evidence (1 reference)
PMID:26220973 SUPPORT Human Clinical
"postnatal growth delay, microcephaly and severe intellectual disability in all four patients, mild shortening of humeri in three patients, and chondrodysplasia punctata in two patients,"
Gives the phenotype with the per-feature counts, including the important observation that the skeletal features were present in only some patients.
Survival beyond the first decade
Unlike classic RCDP1, where death within the first decade is typical, the reported RCDP5 patients survived into the second decade, with clinical assessments recorded at 9.5, 10.5, and 13 years.
Show evidence (1 reference)
PMID:26220973 SUPPORT Human Clinical
"while some individuals lack rhizomelia, show less profound growth and developmental delays, and have longer survival"
Support is partial: the quoted sentence describes the nonclassic RCDP phenotype in general, which is the pattern the reported RCDP5 patients fit, rather than making a survival claim about RCDP5 specifically.
📊

Prevalence

1
Reported patients
Cases In Literature Ultra Rare
The entity was defined on four patients from two independent families, all homozygous for the same frameshift allele. No prevalence estimate exists, and the founding paper argues the entity is likely under-ascertained because its biochemistry is indistinguishable from RCDP1.
Show evidence (1 reference)
PMID:26220973 SUPPORT Human Clinical
"In four patients with RCDP from two independent families, we identified a homozygous frame shift mutation"
Gives the size and structure of the founding cohort.
🔀

Differential Diagnoses

3

Conditions with similar clinical presentations that must be differentiated from Rhizomelic Chondrodysplasia Punctata Type 5:

Overlapping Features The differential that cannot be resolved biochemically. RCDP1 and RCDP5 are the two import-receptor forms and produce the identical selective PTS2 import defect, from the two partners of the same receptor complex. Only sequencing separates them.
Distinguishing Features
  • RCDP1 is caused by PEX7 variants; RCDP5 by variants in the PEX5L-specific exon 9
  • The biochemical profiles are indistinguishable, which is why both genes must be tested
  • The reported RCDP5 patients had milder and less consistent skeletal features than classic RCDP1 and survived into the second decade
Show evidence (1 reference)
PMID:26220973 SUPPORT Human Clinical
"Due to the biochemical overlap between RCDP1 and RCDP5,"
States the biochemical overlap that makes molecular testing necessary.
Overlapping Features The single-enzyme forms, caused by loss of GNPAT, AGPS, or FAR1 rather than by an import defect. They converge on plasmalogen deficiency but lie downstream of import, so phytanic-acid alpha-oxidation is preserved.
Distinguishing Features
  • Phytanic acid is normal in RCDP2/3/4 and elevated in RCDP5
  • The lesion is in a biosynthetic enzyme rather than in peroxisomal protein import
Show evidence (1 reference)
PMID:26220973 SUPPORT Human Clinical
"Three additional RCDP types, RCDP2-3-4, are caused, respectively, by mutations in GNPAT, AGPS and FAR1, encoding enzymes involved in plasmalogen biosynthesis."
Identifies the single-enzyme forms and their genes.
Overlapping Features The other, and far more common, PEX5 phenotype. Variants affecting both isoforms remove PTS1 import and cause a generalized peroxisome biogenesis disorder. The reported RCDP5 patients lacked the ZSD-typical hepatic dysfunction and sensorineural hearing loss.
Distinguishing Features
  • ZSD involves failure of PTS1 import and hence generalized peroxisomal dysfunction; RCDP5 spares PTS1 import entirely
  • Hepatic dysfunction and sensorineural hearing loss are typical of ZSD and were absent in the RCDP5 patients
  • Congenital cataract with chondrodysplasia punctata points towards RCDP rather than ZSD
Show evidence (1 reference)
PMID:26220973 SUPPORT Human Clinical
"lacked several features typically associated with ZSD, such as hepatic dysfunction and sensorineural hearing loss"
Names the ZSD features absent in these patients, which is what separated the two phenotypes clinically before the isoform mechanism was established.
{ }

Source YAML

click to show
name: Rhizomelic Chondrodysplasia Punctata Type 5
creation_date: "2026-08-27T00:00:00Z"
category: Mendelian
description: >-
  Rhizomelic chondrodysplasia punctata type 5 is caused by biallelic PEX5 variants that
  remove the long isoform of the protein while sparing the short one. It exists as a
  distinct entity because of an isoform accident with unusually clean mechanistic
  consequences. PEX5 is the cytosolic receptor for peroxisomal matrix proteins carrying
  targeting signal 1, and it is transcribed as two isoforms: PEX5S, which does PTS1
  import only, and PEX5L, which does PTS1 import and additionally acts as the co-receptor
  through which PEX7 delivers PTS2-tagged cargo. Every previously reported PEX5 patient
  had a Zellweger spectrum disorder, because their variants knocked out PTS1 import.
  The RCDP5 variant sits in exon 9, which is specific to the long isoform, so PTS1 import
  survives intact and only the PTS2 arm fails - reproducing exactly the lesion that PEX7
  loss produces in RCDP1, from the other side of the same receptor complex. One gene
  therefore gives two unrelated diseases depending on which isoform an allele hits, and
  the practical consequence is stated in the founding paper: a patient with a selective
  PTS2 import defect needs PEX7 sequenced and PEX5 exon 9 sequenced, because the
  biochemistry alone will not tell them apart. Clinically the four reported patients had
  congenital cataracts, postnatal growth delay, microcephaly, and severe intellectual
  disability, but only mild humeral shortening in three and chondrodysplasia punctata in
  two - a milder and less consistently rhizomelic skeletal picture than classic RCDP1,
  which matters when deciding whether to look for the disorder at all.
synonyms:
- RCDP5
- PEX5 rhizomelic chondrodysplasia punctata
- Rhizomelic chondrodysplasia punctata, type 5
- PEX5L deficiency
disease_term:
  preferred_term: rhizomelic chondrodysplasia punctata type 5
  term:
    id: MONDO:0014743
    label: rhizomelic chondrodysplasia punctata type 5
parents:
- Rhizomelic Chondrodysplasia Punctata
- Peroxisome Biogenesis Disorder
classifications:
  harrisons_chapter:
  - classification_value: GENETICS_ENVIRONMENT_DISEASE
    notes: >-
      An autosomal recessive Mendelian skeletal dysplasia diagnosed by molecular testing.
  - classification_value: ENDOCRINOLOGY_METABOLISM
    notes: >-
      Also an inborn error of metabolism: the entity is defined by a selective peroxisomal
      protein-import defect with a measurable metabolite signature - reduced plasmalogens
      with elevated phytanic acid.
  icimd_category:
  - classification_value: peroxisomal_biogenesis
    notes: >-
      ICIMD (Ferreira et al. 2021, PMID:33340416): group "Peroxisomal biogenesis disorders
      (peroxin-related)" under category "Disorders of organelle biogenesis, dynamics and
      interactions". PEX5 is a peroxin and the lesion is at the matrix-protein import step,
      which is the same reasoning that places RCDP1 (PEX7) here and distinguishes both from
      the single-enzyme forms RCDP2/3/4, which take "Disorders of glycerophospholipid
      metabolism".
  isds_skeletal_category:
  - classification_value: chondrodysplasia_punctata
    notes: >-
      ISDS Nosology of Genetic Skeletal Disorders, 2023 revision (Unger et al.,
      PMID:36779427), group 23 "Chondrodysplasia punctata (CDP) group", row
      NOS 23-0100 "Rhizomelic CDP, PEX5-related" (MIM 616716). This row is new relative to
      the 2019 revision, which predated wide recognition of the entity; the group itself
      was numbered 21 there. The nosology lists the five rhizomelic-CDP entities as five
      separate rows by gene, and dismech follows that split here rather than folding this
      entity into the PEX7 entry.
mappings:
  mondo_mappings:
  - term:
      id: MONDO:0014743
      label: rhizomelic chondrodysplasia punctata type 5
    mapping_predicate: skos:exactMatch
    mapping_source: MONDO
    mapping_justification: >-
      The dismech entry and the MONDO class denote the same entity: PEX5-related rhizomelic
      chondrodysplasia punctata arising from loss of the PEX5 long isoform. The other PEX5
      phenotype, Zellweger spectrum disorder from loss of PTS1 import, is a separate concept
      and is handled here as a differential.
references:
- reference: PMID:26220973
  title: "A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform."
- reference: PMID:20301447
  title: "PEX7-Related Rhizomelic Chondrodysplasia Punctata."
  tags:
  - GeneReviews
prevalence:
- population: Reported patients
  measure_type: CASES_IN_LITERATURE
  prevalence_class: ULTRA_RARE
  notes: >-
    The entity was defined on four patients from two independent families, all homozygous
    for the same frameshift allele. No prevalence estimate exists, and the founding paper
    argues the entity is likely under-ascertained because its biochemistry is
    indistinguishable from RCDP1.
  evidence:
  - reference: PMID:26220973
    reference_title: "A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In four patients with RCDP from two independent families, we identified a homozygous
      frame shift mutation
    explanation: Gives the size and structure of the founding cohort.
progression:
- phase: Infancy - congenital cataracts
  notes: >-
    All four reported patients had congenital cataracts requiring surgery in the first
    months. As in RCDP1, the cataract is the earliest and most consistent feature and
    typically precedes recognition of the metabolic disorder.
  evidence:
  - reference: PMID:26220973
    reference_title: "A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      the phenotype in our patients, including congenital cataracts,
    explanation: Records congenital cataracts as a feature of the reported cohort.
- phase: Early childhood - growth delay, microcephaly, developmental impairment
  notes: >-
    Growth delay and microcephaly emerge after the first one to two years, with severe
    intellectual disability in all four patients. Seizures with epileptiform EEG developed
    in several.
  evidence:
  - reference: PMID:26220973
    reference_title: "A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      postnatal growth delay, microcephaly and severe intellectual
      disability in all four patients, mild shortening of humeri in
      three patients, and chondrodysplasia punctata in two patients,
    explanation: >-
      Gives the phenotype with the per-feature counts, including the important observation
      that the skeletal features were present in only some patients.
- phase: Survival beyond the first decade
  notes: >-
    Unlike classic RCDP1, where death within the first decade is typical, the reported
    RCDP5 patients survived into the second decade, with clinical assessments recorded at
    9.5, 10.5, and 13 years.
  evidence:
  - reference: PMID:26220973
    reference_title: "A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      while some individuals lack rhizomelia, show less profound
      growth and developmental delays, and have longer survival
    explanation: >-
      Support is partial: the quoted sentence describes the nonclassic RCDP phenotype in
      general, which is the pattern the reported RCDP5 patients fit, rather than making a
      survival claim about RCDP5 specifically.
pathophysiology:
- name: Loss of the PEX5 Long Isoform
  biological_scale: MOLECULAR
  description: >-
    PEX5 is transcribed as two isoforms. Both PEX5L and PEX5S recognize PTS1-tagged cargo,
    but only PEX5L serves as the co-receptor for PEX7-mediated import of PTS2-tagged cargo.
    The RCDP5 frameshift lies in exon 9, which is present only in the long transcript, so
    it removes PEX5L and leaves PEX5S intact. This is the whole mechanism of the disorder
    and the reason it is not a Zellweger spectrum disorder.
  genetic_context:
    functional_impact_category: LOSS_OF_FUNCTION
    variant_origin: GERMLINE
    zygosity: HOMOZYGOUS
    gene:
      preferred_term: PEX5
      term:
        id: hgnc:9719
        label: PEX5
    description: >-
      Homozygous frameshift in the PEX5L-specific exon 9 in all four reported patients from
      two independent families. The functional impact is isoform-selective rather than
      whole-gene: PEX5S is unaffected, which is why PTS1 import is preserved.
  biological_processes:
  - preferred_term: protein import into peroxisome matrix
    modifier: DECREASED
    term:
      id: GO:0016558
      label: protein import into peroxisome matrix
  evidence:
  - reference: PMID:26220973
    reference_title: "A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      PEX5 encodes two isoforms, PEX5L and PEX5S, and we show that the c.722dupA mutation,
      located in the PEX5L-specific exon 9, results in loss of PEX5L only.
    explanation: Establishes the isoform-selective consequence of the variant.
  - reference: PMID:26220973
    reference_title: "A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      We demonstrate that PEX5L expression restores the import of PTS2-tagged proteins in
      patient fibroblasts.
    explanation: >-
      Complementation of patient fibroblasts with PEX5L restores the defective function,
      establishing causation rather than association.
  downstream:
  - target: Selective PTS2 Import Failure
    description: >-
      With PEX5L gone, PEX7 has no co-receptor, so PTS2-tagged cargo is not delivered into
      the peroxisomal matrix, while PTS1 import proceeds through the surviving short
      isoform.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:26220973
      reference_title: "A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        Both PEX5 isoforms recognize PTS1-tagged proteins, but PEX5L is also a co-receptor
        for PTS2-tagged proteins.
      explanation: >-
        The division of labour between the isoforms is what makes the import failure
        selective.
- name: Selective PTS2 Import Failure
  conforms_to: "peroxisomal_metabolic_failure#Peroxisomal Biogenesis or Enzyme Defect"
  biological_scale: CELLULAR
  description: >-
    An isolated failure to import the three known PTS2-tagged peroxisomal matrix proteins:
    alkyl-DHAP synthase (AGPS), which makes the ether bond in plasmalogens; phytanoyl-CoA
    2-hydroxylase (PHYH), which performs phytanic-acid alpha-oxidation; and acetyl-CoA
    acyltransferase 1 (ACAA1). Peroxisomes are otherwise assembled and PTS1 import is
    normal, so this is a targeted functional lesion rather than a general peroxisome
    biogenesis failure - which is why the disorder is an RCDP and not a Zellweger spectrum
    disorder. The node is deliberately named to match the corresponding node in the RCDP1
    entry, since the two disorders converge on it from opposite sides of the same receptor
    pair.
  cellular_components:
  - preferred_term: peroxisome
    term:
      id: GO:0005777
      label: peroxisome
  biological_processes:
  - preferred_term: protein targeting to peroxisome
    modifier: DECREASED
    term:
      id: GO:0006625
      label: protein targeting to peroxisome
  - preferred_term: protein import into peroxisome matrix
    modifier: DECREASED
    term:
      id: GO:0016558
      label: protein import into peroxisome matrix
  evidence:
  - reference: PMID:26220973
    reference_title: "A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Similarly to mutations in PEX7, loss of PEX5L results in deficient import of
      PTS2-tagged proteins only, thus causing RCDP instead of ZSD.
    explanation: >-
      States both the selectivity of the import defect and the nosological consequence that
      follows from it.
  downstream:
  - target: Plasmalogen (Ether Lipid) Deficiency
    description: >-
      Failure to import AGPS impairs ether-phospholipid synthesis. Notably the reduction is
      described as mild in these patients, and the surrogate marker GNPAT activity was also
      reduced - the pattern expected when the PTS2-targeted AGPS fails to reach the matrix.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:26220973
      reference_title: "A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        All RCDP types
        are characterized by low levels of plasmalogens
      explanation: >-
        Establishes plasmalogen deficiency as the shared biochemical endpoint of every RCDP
        type, this one included.
  - target: Phytanic Acid Accumulation
    description: >-
      Failure to import PHYH blocks phytanic-acid alpha-oxidation. This is the feature that
      the import-receptor forms share and that the single-enzyme plasmalogen-synthesis forms
      RCDP2/3/4 do not have, and it is therefore the biochemical discriminator between the
      two mechanistic classes.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:26220973
      reference_title: "A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        Three PTS2-tagged peroxisomal matrix proteins are known:
        AGPS, involved in plasmalogen biosynthesis
      explanation: >-
        Identifies the PTS2 cargo set, whose members' failure to be imported produces both
        the plasmalogen and the phytanic-acid abnormalities.
- name: Plasmalogen (Ether Lipid) Deficiency
  conforms_to: "peroxisomal_metabolic_failure#Toxic Fatty-Acid Accumulation with Ether-Lipid Deficiency"
  biological_scale: MOLECULAR
  description: >-
    Reduced cellular plasmalogens, the shared endpoint of every RCDP type. In the reported
    RCDP5 patients the reduction was mild rather than profound, which fits their milder and
    less consistently rhizomelic skeletal phenotype but also means the disorder can be
    missed on a plasmalogen screen alone.
  biological_processes:
  - preferred_term: ether lipid biosynthesis
    modifier: DECREASED
    term:
      id: GO:0008611
      label: ether lipid biosynthetic process
  evidence:
  - reference: PMID:26220973
    reference_title: "A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Three additional RCDP types, RCDP2-3-4, are caused, respectively, by mutations in
      GNPAT, AGPS and FAR1, encoding enzymes involved in plasmalogen biosynthesis.
    explanation: >-
      Places the plasmalogen pathway as the common convergence point across RCDP types,
      reached here through import failure rather than through enzyme loss.
  downstream:
  - target: Skeletal Dysplasia
    description: >-
      Plasmalogen deficiency is the lesion shared by all RCDP types and the presumed route
      to the skeletal phenotype, though the intervening steps are not established in any of
      them.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Congenital Cataract
    description: >-
      Congenital cataract is the most consistent non-skeletal feature across the RCDP types
      and was present in all four RCDP5 patients; the route from plasmalogen deficiency to
      lens opacity is not established.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Phytanic Acid Accumulation
  biological_scale: MOLECULAR
  description: >-
    Loss of peroxisomal phytanic-acid alpha-oxidation, following failure to import PHYH.
    In the reported patients plasma phytanic acid was highly elevated and fibroblast
    alpha-oxidation markedly reduced - a more striking abnormality than their mild
    plasmalogen reduction, and the finding that most clearly marks the disorder as an
    import-receptor rather than a single-enzyme RCDP.
  biological_processes:
  - preferred_term: fatty acid alpha-oxidation
    modifier: DECREASED
    term:
      id: GO:0001561
      label: fatty acid alpha-oxidation
  evidence:
  - reference: PMID:26220973
    reference_title: "A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      phytanoyl-CoA
      2-hydroxylase (PHYH) (28), involved in phytanic acid
    explanation: >-
      Identifies phytanoyl-CoA 2-hydroxylase, the enzyme of phytanic-acid alpha-oxidation, as
      PTS2-tagged cargo - so a selective PTS2 import failure necessarily blocks that pathway.
  downstream:
  - target: Neurological Impairment
    description: >-
      Phytanic acid accumulation is neurotoxic in the peroxisomal disorders generally; the
      specific contribution it makes to the developmental and peripheral-nerve findings in
      this disorder is not separable from that of plasmalogen deficiency on the available
      evidence.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Skeletal Dysplasia
  biological_scale: TISSUE
  description: >-
    Disordered endochondral ossification with punctate epiphyseal calcification and
    proximal limb shortening. In RCDP5 this arm of the phenotype is attenuated relative to
    classic RCDP1: humeral shortening was mild and present in three of four patients, and
    chondrodysplasia punctata in only two.
  cell_types:
  - preferred_term: chondrocyte
    term:
      id: CL:0000138
      label: chondrocyte
  - preferred_term: growth plate cartilage chondrocyte
    term:
      id: CL:1000217
      label: growth plate cartilage chondrocyte
  biological_processes:
  - preferred_term: endochondral ossification
    modifier: ABNORMAL
    term:
      id: GO:0001958
      label: endochondral ossification
  evidence:
  - reference: PMID:26220973
    reference_title: "A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      mild shortening of humeri in
      three patients, and chondrodysplasia punctata in two patients,
    explanation: >-
      Gives the frequency and severity of the two skeletal features in the founding cohort.
  downstream:
  - target: Epiphyseal Stippling
    causal_link_type: DIRECT
    description: Punctate epiphyseal calcification, present in two of the four reported patients.
  - target: Short Humerus
    causal_link_type: DIRECT
    description: Mild proximal (rhizomelic) shortening of the upper limb.
- name: Neurological Impairment
  biological_scale: ORGANISM
  description: >-
    Severe intellectual disability in all four patients, with microcephaly, seizures with
    epileptiform EEG, and in at least one patient findings compatible with a chronic
    demyelinating peripheral neuropathy - the last being a feature more usually associated
    with the Zellweger spectrum than with classic RCDP.
  evidence:
  - reference: PMID:26220973
    reference_title: "A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      postnatal growth delay, microcephaly and severe intellectual
      disability in all four patients
    explanation: States the neurological findings and that they were present in all four patients.
  downstream:
  - target: Severe Intellectual Disability
    causal_link_type: DIRECT
    description: Severe intellectual disability was present in all four reported patients.
  - target: Microcephaly
    causal_link_type: DIRECT
    description: Microcephaly developed postnatally.
  - target: Seizure
    causal_link_type: DIRECT
    description: Seizures with epileptiform EEG activity developed in several patients.
phenotypes:
- name: Congenital Cataract
  category: Visual
  diagnostic: true
  description: >-
    Bilateral cataracts present at birth and operated in the first months of life in all
    four reported patients - the earliest and most consistent feature, as in the other RCDP
    types.
  phenotype_term:
    preferred_term: Cataract
    term:
      id: HP:0000518
      label: Cataract
    onset:
      onset_category: CONGENITAL
  evidence:
  - reference: PMID:26220973
    reference_title: "A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In contrast, some of their
      key features such as congenital cataracts and chondrodysplasia
      punctata are usually associated with RCDP
    explanation: >-
      Records congenital cataract in the cohort and identifies it as an RCDP-typical rather
      than ZSD-typical feature.
- name: Epiphyseal Stippling
  category: Skeletal
  description: >-
    Punctate epiphyseal calcification, present in two of the four reported patients - less
    consistent than in classic RCDP1.
  phenotype_term:
    preferred_term: Epiphyseal stippling
    term:
      id: HP:0010655
      label: Epiphyseal stippling
  evidence:
  - reference: PMID:26220973
    reference_title: "A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "and chondrodysplasia punctata in two patients,"
    explanation: Gives the frequency of the punctate calcification in the founding cohort.
- name: Short Humerus
  category: Skeletal
  description: >-
    Mild rhizomelic shortening of the humerus in three of four patients. The mildness is
    diagnostically important: an RCDP without striking rhizomelia is easy to miss.
  phenotype_term:
    preferred_term: Short humerus
    term:
      id: HP:0005792
      label: Short humerus
    severity: MILD
  evidence:
  - reference: PMID:26220973
    reference_title: "A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      mild shortening of humeri in
      three patients
    explanation: States the severity and frequency of the humeral shortening.
- name: Severe Intellectual Disability
  category: Neurologic
  description: Severe intellectual disability in all four reported patients.
  phenotype_term:
    preferred_term: Severe intellectual disability
    term:
      id: HP:0010864
      label: Severe intellectual disability
  evidence:
  - reference: PMID:26220973
    reference_title: "A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      microcephaly and severe intellectual
      disability in all four patients
    explanation: States the finding and its frequency.
- name: Microcephaly
  category: Neurologic
  description: Postnatally acquired microcephaly, emerging after the first one to two years.
  phenotype_term:
    preferred_term: Microcephaly
    term:
      id: HP:0000252
      label: Microcephaly
  evidence:
  - reference: PMID:26220973
    reference_title: "A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      postnatal growth delay, microcephaly and severe intellectual
      disability in all four patients
    explanation: States microcephaly in all four patients.
- name: Postnatal Growth Retardation
  category: Growth
  description: Growth delay emerging after infancy in all four reported patients.
  phenotype_term:
    preferred_term: Postnatal growth retardation
    term:
      id: HP:0008897
      label: Postnatal growth retardation
  evidence:
  - reference: PMID:26220973
    reference_title: "A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "postnatal growth delay, microcephaly and severe intellectual"
    explanation: States postnatal growth delay in the cohort.
- name: Seizure
  category: Neurologic
  description: Seizures with epileptiform activity on EEG developed in several of the reported patients.
  phenotype_term:
    preferred_term: Seizure
    term:
      id: HP:0001250
      label: Seizure
  evidence:
  - reference: PMID:26220973
    reference_title: "A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "developed seizures, and an EEG"
    explanation: Documents seizures with EEG confirmation in a reported patient.
genetic:
- name: PEX5
  relationship_type: CAUSATIVE
  presence: Present
  gene_term:
    preferred_term: PEX5
    term:
      id: hgnc:9719
      label: PEX5
  notes: >-
    PEX5 is the striking case of one gene giving two unrelated diseases according to which
    isoform an allele affects. Variants hitting both isoforms remove PTS1 import and cause
    a Zellweger spectrum disorder; the exon 9 variant hits only PEX5L, leaves PTS1 import
    intact, and causes RCDP5. Any diagnostic strategy that does not cover exon 9
    specifically will miss this entity in a patient whose biochemistry looks like RCDP1.
  evidence:
  - reference: PMID:26220973
    reference_title: "A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Previous patients with PEX5 mutations had ZSD, mainly due to deficient import of
      PTS1-tagged proteins.
    explanation: >-
      Establishes the contrasting PEX5 phenotype and the import defect that produces it.
  - reference: PMID:26220973
    reference_title: "A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Mutations in PEX5 or 12 other PEX genes cause peroxisome biogenesis disorders,
      collectively named the Zellweger spectrum disorders (ZSDs), whereas mutations in PEX7
      cause rhizomelic chondrodysplasia punctata type 1 (RCDP1).
    explanation: >-
      States the pre-existing gene-disease assignments that RCDP5 complicates, since it
      places PEX5 on both sides of that division.
inheritance:
- name: Autosomal recessive inheritance
  inheritance_term:
    preferred_term: autosomal recessive inheritance
    term:
      id: HP:0000007
      label: Autosomal recessive inheritance
  description: >-
    All four reported patients were homozygous for the same frameshift allele, in two
    independent families.
  evidence:
  - reference: PMID:26220973
    reference_title: "A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In four patients with RCDP from two independent families, we identified a homozygous
      frame shift mutation
    explanation: Documents homozygosity in two independent families.
biochemical:
- name: Erythrocyte or fibroblast plasmalogens
  notes: >-
    Reduced, but only mildly so in the reported patients - a softer signal than in classic
    RCDP1. GNPAT activity in fibroblasts was also reduced, which is the expected surrogate
    when the PTS2-targeted AGPS fails to reach the peroxisomal matrix.
  evidence:
  - reference: PMID:26220973
    reference_title: "A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      All RCDP types
      are characterized by low levels of plasmalogens
    explanation: Establishes reduced plasmalogens as the expected finding in every RCDP type.
- name: Plasma phytanic acid
  notes: >-
    Highly elevated, with markedly reduced fibroblast phytanic-acid alpha-oxidation. This
    is the discriminator from RCDP2/3/4, where alpha-oxidation is preserved, and it is
    shared with RCDP1 - so it separates the mechanistic class but not the two entities
    within it.
  evidence:
  - reference: PMID:26220973
    reference_title: "A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      phytanoyl-CoA
      2-hydroxylase (PHYH) (28), involved in phytanic acid
    explanation: >-
      Identifies phytanoyl-CoA 2-hydroxylase as PTS2-tagged cargo, which is why an import
      defect raises phytanic acid while a defect in a plasmalogen-synthesis enzyme does not.
diagnosis:
- name: Sequencing PEX7 and PEX5 exon 9 in a selective PTS2 import defect
  description: >-
    Because RCDP1 and RCDP5 are biochemically indistinguishable, a patient shown to have a
    selective PTS2 import defect needs both genes tested. The founding paper makes this an
    explicit recommendation, and it is the disorder's main practical consequence for
    laboratory workflow.
  diagnosis_term:
    preferred_term: molecular genetic testing
    term:
      id: NCIT:C15709
      label: Genetic Testing
  evidence:
  - reference: PMID:26220973
    reference_title: "A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Due to the biochemical overlap between RCDP1 and RCDP5, sequencing of PEX7 and exon 9
      in PEX5 should be performed in patients with a selective defect in the import of
      PTS2-tagged proteins.
    explanation: States the testing recommendation and the reason for it.
treatments:
- name: Supportive and rehabilitative care
  description: >-
    No disease-modifying therapy exists. Management follows the RCDP pattern: cataract
    surgery, developmental and orthopedic support, and seizure management.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: supportive care
    term:
      id: NCIT:C15747
      label: Supportive Care
  evidence:
  - reference: PMID:20301447
    reference_title: PEX7-Related Rhizomelic Chondrodysplasia Punctata.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Physical therapy to improve contractures; orthopedic procedures may improve function
      in some individuals; consider need for positioning and mobility devices
    explanation: >-
      Support is partial: the source describes management of PEX7-related RCDP, and is cited
      here on the basis that RCDP5 shares its lesion and clinical problems. No
      RCDP5-specific management literature exists.
- name: Cataract extraction
  description: Surgical removal of the congenital cataracts, performed in the first months of life in all four reported patients.
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: surgical procedure
    term:
      id: NCIT:C15329
      label: Surgical Procedure
  target_phenotypes:
  - preferred_term: cataract
    term:
      id: HP:0000518
      label: Cataract
  evidence:
  - reference: PMID:26220973
    reference_title: "A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Congenital cataracts were operated
      at 4 months
    explanation: Documents cataract surgery in the reported cohort.
differential_diagnoses:
- name: Rhizomelic chondrodysplasia punctata type 1 (PEX7)
  disease_term:
    preferred_term: rhizomelic chondrodysplasia punctata type 1
    term:
      id: MONDO:0008972
      label: rhizomelic chondrodysplasia punctata type 1
  description: >-
    The differential that cannot be resolved biochemically. RCDP1 and RCDP5 are the two
    import-receptor forms and produce the identical selective PTS2 import defect, from the
    two partners of the same receptor complex. Only sequencing separates them.
  distinguishing_features:
  - RCDP1 is caused by PEX7 variants; RCDP5 by variants in the PEX5L-specific exon 9
  - The biochemical profiles are indistinguishable, which is why both genes must be tested
  - The reported RCDP5 patients had milder and less consistent skeletal features than classic RCDP1 and survived into the second decade
  evidence:
  - reference: PMID:26220973
    reference_title: "A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Due to the biochemical overlap between RCDP1 and RCDP5,"
    explanation: States the biochemical overlap that makes molecular testing necessary.
- name: Rhizomelic chondrodysplasia punctata, plasmalogen-synthesis defect (RCDP2/3/4)
  disease_term:
    preferred_term: rhizomelic chondrodysplasia punctata
    term:
      id: MONDO:0015776
      label: rhizomelic chondrodysplasia punctata
  description: >-
    The single-enzyme forms, caused by loss of GNPAT, AGPS, or FAR1 rather than by an
    import defect. They converge on plasmalogen deficiency but lie downstream of import, so
    phytanic-acid alpha-oxidation is preserved.
  distinguishing_features:
  - Phytanic acid is normal in RCDP2/3/4 and elevated in RCDP5
  - The lesion is in a biosynthetic enzyme rather than in peroxisomal protein import
  evidence:
  - reference: PMID:26220973
    reference_title: "A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Three additional RCDP types, RCDP2-3-4, are caused, respectively, by mutations in
      GNPAT, AGPS and FAR1, encoding enzymes involved in plasmalogen biosynthesis.
    explanation: Identifies the single-enzyme forms and their genes.
- name: Zellweger spectrum disorders
  disease_term:
    preferred_term: Zellweger spectrum disorders
    term:
      id: MONDO:0019609
      label: Zellweger spectrum disorders
  description: >-
    The other, and far more common, PEX5 phenotype. Variants affecting both isoforms remove
    PTS1 import and cause a generalized peroxisome biogenesis disorder. The reported RCDP5
    patients lacked the ZSD-typical hepatic dysfunction and sensorineural hearing loss.
  distinguishing_features:
  - ZSD involves failure of PTS1 import and hence generalized peroxisomal dysfunction; RCDP5 spares PTS1 import entirely
  - Hepatic dysfunction and sensorineural hearing loss are typical of ZSD and were absent in the RCDP5 patients
  - Congenital cataract with chondrodysplasia punctata points towards RCDP rather than ZSD
  evidence:
  - reference: PMID:26220973
    reference_title: "A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      lacked several features
      typically associated with ZSD, such as hepatic dysfunction and
      sensorineural hearing loss
    explanation: >-
      Names the ZSD features absent in these patients, which is what separated the two
      phenotypes clinically before the isoform mechanism was established.
discussions:
- discussion_id: rcdp5_phenotypic_boundary
  kind: KNOWLEDGE_GAP
  status: OPEN
  attaches_to:
  - pathophysiology#Skeletal Dysplasia
  - disease#Rhizomelic Chondrodysplasia Punctata Type 5
  prompt: >-
    Is the milder, less consistently rhizomelic skeletal phenotype of RCDP5 a real property
    of the disorder, or an artefact of the single allele on which the entity was defined?
  rationale: >-
    All four described patients are homozygous for one frameshift in two families, so the
    entity's clinical description and its genotype are entirely confounded. The reported
    phenotype - chondrodysplasia punctata in only two of four, mild humeral shortening in
    three, survival into the second decade - is milder than classic RCDP1 and would fit the
    nonclassic RCDP pattern. Whether that reflects the isoform lesion, this particular
    allele, or the two families is untestable on the published cohort. It matters for
    ascertainment: if RCDP5 is genuinely milder, patients are being missed, since a
    plasmalogen screen showing only mild reduction in a child without striking rhizomelia is
    unlikely to prompt PEX5 exon 9 sequencing.
  proposed_experiments:
  - experiment_id: rcdp5_allelic_series
    name: Broader ascertainment of PEX5L-selective alleles
    description: >-
      Targeted analysis of PEX5 exon 9 in cohorts with a selective PTS2 import defect and no
      PEX7 variant, to determine whether other PEX5L-selective alleles exist and whether
      they reproduce the attenuated skeletal phenotype.
  evidence:
  - reference: PMID:26220973
    reference_title: "A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      mild shortening of humeri in
      three patients, and chondrodysplasia punctata in two patients,
    explanation: >-
      The per-feature counts show that the defining skeletal features were not present in
      every patient, which is the observation the question turns on.
notes: >-
  Curated as its own dismech entry rather than merged into the PEX7 entry, even though the
  two share a mechanism node. Three reasons. The ISDS 2023 nosology lists the five
  rhizomelic-CDP entities as five separate rows by gene, and NOS 23-0100 is this one.
  MONDO carries a distinct class, MONDO:0014743. And the interesting content here is
  gene-specific rather than mechanism-specific: it is the isoform-selective allele that
  makes one gene give two unrelated diseases, which has no counterpart in the PEX7 entry.
  This is a different judgement from the one made for RCDP2/3/4, which dismech lumps into a
  single entry - there the three genes are consecutive steps of one biosynthetic pathway
  with nothing gene-specific to say, whereas here the gene is the story. A member of the
  Chondrodysplasia_Punctata grouping.

  The two pathophysiology nodes shared with RCDP1 carry the same conforms_to links to the
  peroxisomal_metabolic_failure module that the RCDP1 entry uses, since the lesion is the
  same at both nodes - that is the whole point of naming them identically.

  The GeneReviews-tagged reference (PMID:20301447) is the PEX7/RCDP1 chapter, not an RCDP5
  chapter: none exists. It is cited once, for supportive management, and graded PARTIAL for
  that reason. Deep-mining a PEX7 chapter for a PEX5 disease would be an entity-confusion
  error, so the restraint is deliberate.
📚

References & Deep Research

References

2
A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform.
No top-level findings curated for this source.
PEX7-Related Rhizomelic Chondrodysplasia Punctata.
No top-level findings curated for this source.